Financials
- Market Capitalization 392.49 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-6.23
市销率
0.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2932 | AQST Aquestive Therapeutics, Inc. - Common Stock | 3.96 USD | -1.98% | -6.60% | -5.71% | -2.46% | 496.78 M USD | ||
| 3068 | KMDA Kamada Ltd. - Ordinary Shares | 7.18 USD | -1.24% | -0.83% | -3.10% | -5.40% | 414.19 M USD | ||
| 3085 | CGC Canopy Growth Corporation - Common Shares | 0.96 USD | 0.00% | +1.05% | -3.03% | -13.51% | 405.27 M USD | ||
| 3123 | EBS Emergent BioSolutions Inc. Common Stock | 7.53 USD | +0.27% | -7.72% | -9.28% | -29.76% | 388.52 M USD |